Two reciprocal interspecies hybrid class I histocompatibility genes have been constructed between genomic clones of human HLA-A2 and murine 
cell RD transformants as well. In both cases, the level of CTL recognition and lysis of the transformants that expressed the native antigen Kb was greater than of those transformants that expressed the hybrid antigen Kbl+2/A2. These data suggest that the carboxyl-terminal domains play some role in CTL allorecognition. The lack of human CTL recognition of HLA molecules expressed in mouse L cells, however, cannot be explained by the presence of a xenogeneic carboxyl terminus. Since murine CTL can recognize their target antigen when expressed on the surface of human cells, the possibility remains either that a ligand necessary for other molecular interactions of human CTL may be absent on mouse target cells or that murine and human CTL differ in affinity of binding to target antigens in the absence of accessory-molecule interactions.
The class I histocompatibility antigens are membrane proteins that appear to act as recognition structures for allospecific and virus-restricted cytolytic T lymphocytes (CTL) (1) . Recently, the availability and the characterization of genomic clones for class I molecules have provided a new approach to study the specificity of CTLtarget cell interactions. Genomic clones for murine H-2 antigens have been expressed in recipient cells after transformation, in association with the endogenous 182-microglobulin (2) . Newly expressed H-2 antigens bind appropriate alloantibodies and act as targets for alloantigen-and virus-specific H-2-restricted mouse CTL (2) . In addition, a variety of reconstructions of the H-2 genes have been made that, when expressed, code for hybrid class I proteins. Results of these studies have (i) confirmed earlier biochemical studies (3) (4) (5) by showing that CTL and most monoclonal antibody (mAb) recognition sites are located in the al and a2 domains (6) (7) (8) (9) (10) , (it) suggested that there may be specific conformational interactions between the al and a2 domains required for the stability of antigenic determinants (8, 9, 11) , and (iii) showed that class I proteins that lacked or had altered cytoplasmic domains were normally mobile in the membrane and were recognized by allospecific and most viral-specific CTL (12, 13) .
Similar studies were performed with human HLA genes. Newly expressed HLA class I gene products can bind appropriate alloantibodies, when expressed in either human or mouse cells (14) (15) (16) (17) , and act as targets for human allospecific CTL when expressed in human cells (16, 17) . However, mouse cells that express human class I genes have been found not to be lysed by human allospecific CTL (14) (15) (16) (17) , although a small number of mouse xenogeneic CTL clones have been reported to lyse HLA-transfected mouse L cells (18) .
In this study, we have investigated whether the lack of CTL recognition of HLA molecules when expressed in mouse cells was due to inappropriate associations of HLA proteins with the target cell membrane or cytoskeletal proteins. Two interspecies hybrid class I molecules between HLA-A2 and H-2Kb were constructed and designated as follows: A21+2/Kb, a hybrid protein that contains the al and a2 domains of the HLA-A2 molecule covalently linked to the a3 domain and the remaining domains of H-2Kb, and Kbl+2/A2, the reciprocal protein that contains the al and a2 domains of the H-2Kb molecule linked to the carboxylterminal domains [the third external domain (a3), the transmembrane domain, and the intracytoplasmic domain] of HLA-A2. With these constructions, we demonstrate that despite the appropriate murine carboxyl terminus, the interspecies class I protein that contains the polymorphic domains, al and a2, of the HLA molecule still is not recognized by human allospecific CTL when expressed in murine cells. However, some experiments indicate that the carboxyl-terminal domains play a small but significant role in CTL allorecognition.
MATERIALS AND METHODS
Animals. C57BL/6J (H-2b) and C3H/HeJ (H-2k) mice and Lewis rats were obtained from The Jackson Laboratory and maintained at the Michael Redstone Memorial Laboratory (Dana-Farber Cancer Institute).
Proc. Natl. Acad. Sci. USA 82 (1985) 6277 Cell Lines. All adherent tissue cell lines were grown and tested in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 2 mM L-glutamine (GIBCO), 1% nonessential amino acids (GIBCO), and penicillin (100 units/ml)/streptomycin (100 units/ml) (GIBCO). Cells were passaged after removal from tissue culture dishes (Falcon) with Versene (Na4EDTA) 1:5000 (GIBCO). All CTL lines were maintained in RPMI 1640 medium (M. A. Bioproducts, Walkersville, MD)/10% fetal calf serum/2 mM L-glutamine/penicillin (100 units/ml)/streptomycin (100 units/ml)/50 ,uM 2-mercaptoethanol (Eastman Organic Chemicals, Rochester, NY), containing 10% rat or human lymphocyte-conditioned medium (19) as a source of interleukin 2 and other T-cell factors (complete medium). Specific tumor cell lines used included JY (an Epstein-Barr virustransformed lymphoblastoid B-cell line), LTK-(a thymidinekinase deficient mouse fibroblast line), RD (a human rhabdomyosarcoma line), and EL4 (a mouse thymoma line).
Construction of Class I Hybrid Genomic Clones. The HLA-A2 gene (pB3.2) had been cloned in the EcoRI site of pBR328 (16) . Isolates with the gene in both orientations were generated subsequently. The H-2Kb gene was cloned in the EcoRI site of pBR327 (8) . Exons 1-3 of H-2Kb were isolated in a 4.8-kilobase (kb) BamHI fragment and exons 4-8 in a 2.35-kb BamHI fragment. Exons 1-3 of HLA-A2, together with the ampicillin-resistance gene and the origin of replication of pBR328, were isolated in a 6-kb BamHI/Bgl II fragment. Exons 4-7 of HLA-A2 with the same vector sequences were isolated in an 8.1-kb BamHI/Bgl II fragment from the subclone with the reverse orientation ofHLA-A2. Restriction fragments were separated by electrophoresis in a low melting point 0.6% agarose (Sigma) gel. Fragments were isolated by melting the gel slices at 65°C, followed by phenol extraction and ethanol-precipitation to recover the DNA. The vector fragments were treated with calf intestinal phosphatase (Boehringer Mannheim) for 60 min at 37°C. Ligations were performed in the presence of T4 DNA ligase (New England Biolabs). Ligated DNAs were introduced into Escherichia coli HB101 cells. Colonies were picked and constructs were identified by restriction enzyme digestion of plasmid DNA minipreparations. Plasmid DNA for transformation of L cells was isolated from plasmid maxipreparations by alkaline lysis followed by purification on cesium chloride gradients (20) . Appropriate exon-exchange and correct orientation of the insert were confirmed by restriction enzyme analysis.
Transformations. DNA-mediated gene transfer was performed by a modification of the calcium phosphate transfection procedure (21) . Cells were cotransfected with the class I gene and with the gene encoding the bacterial aminoglycoside 3'-phosphotransferase type 11 (22) , which had been linked to the long terminal repeat of the Moloney murine sarcoma virus (gift of D. Faller, Dana-Farber Cancer Institute) and conferred resistance to the antibiotic G418 (geneticin sulfate, GIBCO); 10-15 days after transfection, discrete colonies were visualized, isolated, and then grown in tissue culture.
mAbs. H-2Kb-reactive mAbs used include K7-65 (23), K7-309 (23), K10-56.1 (23), 28-13-3S (24), 28-8-6S (24) , and B8-24-3 (25) . HLA-A2-reactive mAbs include PA2.1 (26), MA2.1 (26), BB7.2 (27) , and 4B (28) . In addition, W6/32 (29) , 15-1-5P (30), P20 (31) , and PY102 (31), which react with a monomorphic determinant on all HLA molecules, with H-2Kk with H-2Dk, and with influenza A/PR8 hemagglutinin 1, respectively, were used.
Analysis by Flow Cytometry. mAbs directed against the desired cell surface antigen were incubated at 4°C for 60 min with 106 cells in 100 Al of culture supernatant in 15-ml conical centrifuge tubes (Falcon). They were extensively washed with DMEM plus 1% fetal calf serum and then incubated with fluorescein isothiocyanate-conjugated F(ab')2 sheep antimouse IgG (Cappel Laboratories, Cochranville, PA) at a dilution of 1:25 in DMEM at 40C for 60 min. Cells were washed three times and resuspended in 0.5 ml of DMEM. If cells were to be sorted and collected sterilely, no further manipulations were performed and the cells were kept at 40C. If the cells were being used for analysis only, 0.5 ml of 2% paraformaldehyde was added. Sorting and/or analysis was performed on an EPICS V cell-sorter (Coulter).
Generation of Mouse CTL Lines. CTL lines used within these studies include a murine C3H (H-2'9 anti-C57BL/6J (H-2b) line derived from mouse splenocytes. Initially, 5 x 106 irradiated H-2b stimulator cells and 5 x 106 H_2k responder cells were cultured in complete medium. Recovery of the responders on a Ficoll-Hypaque (Bionetics, Charleston, SC) gradient and restimulation with antigen was performed two times per week for the first 2 weeks. Effectors then were added at 106 cells per well and restimulated every 7-14 days with 106 irradiated stimulators in medium with 10% conditioned medium as a source of interleukin 2 and other factors. Generation of Human CTL Lines. The human anti-HLA-A2,B7 allogeneic line (gift of S. Mentzer) was generated by stimulating 5 x 106 human peripheral blood lymphocytes (HLA-All, Aw37, B27, BwSJ) with 106 irradiated JY cells (HLA-A2,B7 homozygous). Generation of the line was performed as described above.
Cytotoxicity. Cytotoxicity assays were performed as described (7).
RESULTS

Expression of Parental and Interspecies Hybrid Class I
Genes. The hybrid class I genes 5'Kb/3'A2, which encodes Kbl+2/A2, and 5'A2/3'Kb, which encodes A21+2/Kb, were constructed as described in Materials and Methods. The native H-2Kb and HLA-A2 genes and the two H-2/HLA hybrid genes were introduced into mouse L cells (H-2I) and human RD cells (HLA-AJ, Bw5J, B14). Individual clones were selected and evaluated for expression of the native and hybrid antigens (Fig. 1) by flow cytometry using a pool of mAbs directed at the appropriate gene product. Of the G418-resistant L-cell transformants, 60-80% were found to express the transfected class I gene product, whereas wider variation of expression was found within the RD cells (10-60%). The individual L-cell or RD-cell clones that expressed the highest levels of the native or hybrid antigen were kept for further study. As depicted in Fig. 2 (Fig. 2B) was the lowest.
On the RD transformant expressing the intact HLA-A2 (A2) antigen, slightly greater levels of the class I antigen were present compared to the hybrid (Fig. 2B) . However, these antigen levels accounted for <10% of the total endogenous HLA expression on the RD cell, as measured by the mAb W6/32, a mAb that recognizes a determinant on all HLA-A, -B, and -C antigens. In contrast, the expression of the antigens A2 and A2'12/Kb was 8 and 10 times greater on L cells ( Fig. 2A) (Fig. 2D) . The level of expression of the Kbl+2/A2 antigen on the RD-cell line was 2-fold greater than that on the clone that expressed Kb. However, once again, these levels were lower by a factor of 8-10 than the endogenous HLA antigen expressed on the RD cell surface.
Another panel of L-cell transformants with near equivalent surface expression of the native and hybrid antigens was evaluated with five mAbs directed against the A2 antigen (Table 1) calculated from the channel number that correlates with the peak log fluorescence intensity relative to the fluorescence intensity of the negative control, as described (32) . Negative control mAbs included P20 and PY102 which correlated with the degree of autofluorescence when these lines were cultured with medium and F(ab')2 anti-mouse IgG alone. Values represented here were obtained by subtracting the linear value for the peak log fluorescence for each mAb with the mock-transfected L-cell line from the experimental.
recipient RD cells (data not shown). In addition, these experiments allow the monomorphic determinant recognized by the mAb W6/32 on all HLA-A, -B, and -C antigens to be mapped to either the al or a2 domains of HLA, since the mAb binds to the hybrid A21+2/Kb antigen (Table 1) but not to the Kbl+2/A2 antigen expressed in mouse L cells (Table 2) . This is surprising because the O3 domain, which demonstrates >95% amino acid sequence homology within a given species, would have seemed to be the most likely candidate for the location of a monomorphic epitope. CTL Recognition of L-Cell Transformants. The L-cell transformants expressing the A2 parental and the A21+2/Kb hybrid antigens were assessed for cytolysis by a human HLA-A2,B7-specific long-term human CTL line. As reported (13) , neither the A2+ L cell nor the mock-transfected control L cell line was effectively lysed by the human allospecific CTL despite high surface-expression levels of the antigen (Fig. 3A) . However, this CTL line could lyse the human RD transformant that expresses A2 (see next section or Fig. 3C) . A parallel evaluation of the L-cell line that expresses the hybrid A21+2/Kb antigen was performed. Despite the apparent association of an appropriate mouse carboxyl terminus with the mouse cell membrane, human allospecific CTL did not lyse L cells that expressed the A21+2/Kb hybrid class I molecule (Fig. 3B) . These experiments suggest that the lack of CTL recognition of HLA antigens expressed in murine To further examine the influence of the carboxyl-terminal domains, a murine H-2b-specific CTL line was used to evaluate the L-cell lines that express the Kb and Kbl+2/A2
antigens. Both the Kb-expressing L-cell transformant and Kbl+2/A2-expressing L-cell transformant were lysed (Fig. 4 A and B). However, it should be noted that the level of lysis of the L cells bearing the native antigen was consistently greater than that of the L cells expressing the hybrid antigen, despite the fact that the cell surface expression level of the hybrid antigen Kbl+2/A2 was greater than that of the native antigen Kb. Therefore, this suggests that the carboxylterminal domains may make a significant contribution to the affinity of the CTL for its target antigen. CTL Recognition of RD-Cell Transformants. Evaluation of the human cell transformants that expressed the parental (A2, Kb) and hybrid (A2+2/Kb, Kbl+2/A2) antigens was performed with the human anti-HLA-A2,B7-allospecific CTL line. The recognition and lysis of the native A2 antigen when expressed in a human host has been described (15, 16) and is demonstrated in Fig. 3C . In addition, these human CTL were able to recognize and lyse the A21+2/Kb antigen expressed in the human cell despite the presence of the mouse carboxylterminal domains (Fig. 3D) . Again, it should be noted that lysis of the transformant expressing the hybrid antigen was slightly diminished.
We next examined the human RD cells that expressed the murine Kb and Kbl+2/A2 antigens with the H-2b specific murine CTL line. Surprisingly, these lines were lysed by the mouse CTL despite being expressed in a xenogeneic cell (Fig.  4 C and D) , in contrast to the mouse L cells that express the A2 and A21+2/Kb gene products, where no lysis by human allospecific CTL was seen. Also, despite higher expression levels of the hybrid antigen (Fig. 2D) , once again the Kb-expressing RD transformant was more susceptible to lysis by the mouse CTL (Fig. 4 C and D) , again suggesting that the carboxyl-terminal domains of the class I molecule may exert some influence on CTL recognition.
DISCUSSION
This report describes the construction of interspecies hybrid class I genes and examines the ability of the hybrid antigens encoded by these genes to function as alloantigens. These specific hybrid genes were constructed to introduce the greatest amount of amino acid disparity within the carboxylterminal domains and still maintain the integrity of the class I molecule. This would allow the best assessment of whether the polymorphic domains, al and a2 [to which all CTL allodeterminants examined to date have been mapped (3) (4) (5) (6) (7) (8) (9) (10) ], were influenced by their carboxyl-terminal region, presumably without disruption of the overall structure of the class I major histocompatibility antigen. Species-specific amino acid sequence conservation in the carboxyl-terminal domains is lost in these hybrid antigens. In addition to affecting the conformations of the al and a2 domains, these changes might also affect other molecular interactions. Specifically, the a3 domain [which has -95% amino acid sequence conservation within a species (33) ] may be the location of monomorphic determinants that serve as ligands for certain CTL accessory molecules [i.e., T8 (34) (35) (36) or Lyt2 (37, 38) ] believed to be involved in the adhesion and lytic steps of the CTL-target cell interactions.
A comparison of the human HLA-A2 and the mouse H-2Kb amino acid sequences (ref. 33 and unpublished work) shows that sequence homology within the al, a2, and a3 domains is -70%. However, the disparity within the transmembrane and the intracytoplasmic regions is larger, the homology being only 35% and 45%, respectively. Moreover, the human HLA-A2 molecule lacks the final nine amino acids of the intracytoplasmic domain encoded by exon 8 in the mouse.
Despite this great degree of amino acid sequence variability and its possible effect on the conformation of the external domains, mAb and CTL determinants located within the two most external domains, al and a2, do not appear to be perturbed. In all cases in which the parental class I antigen was capable of being recognized by mAb or CTL, the hybrid antigen was also recognized.
However, some quantitative loss of CTL recognition of the hybrid antigen as compared to the native antigen was observed even with equivalent levels of surface antigen expression (Fig. 4) may decrease the affinity ofthe T-cell receptor of the CTL for its target cell determinants in the al and a2 domains and (ii) if the a3 domain contains amino acid sequences that act as ligands for CTL accessory molecules, such as T8 or Lyt2, then a diminished level of lysis of target cells bearing the hybrid class I molecule might be due to the lack of recognition by low-affinity CTLs which require T8 or Lyt2 (37, 38) to interact with these targets. It seems unlikely that the differences in the intracytoplasmic regions of these proteins would cause this effect, since investigators who have altered or deleted the cytoplasmic region have been unable to demonstrate a defect in allorecognition and have reported only limited effects on H-2-restricted viral recognition (9, 12, 13) . The amino acid differences within the transmembrane region should have little effect on the external polymorphic domains; the conservation of hydrophobicity is necessary for anchoring of the molecule within the membrane (33) .
The possibility that the carboxyl terminus may account for the lack of functional recognition of the HLA molecule in the mouse L cell by human CTLs can now be discounted. This lack of recognition cannot be attributed to the lack of human ,32-microglobulin with a subsequent conformational loss of CTL determinants (15) , diminished expression levels of the class I HLA antigen on the mouse cell (16), or a primary defect in the ability of the L cell to be lysed by CTL (14) . In addition, conjugate studies (data not shown) and "coldtarget" competitive inhibition studies (15) have shown that the human CTL could not bind to the HLA' L cell (the first step in the CTL-target cell interactions). The inability to recognize and lyse the murine HLA' L-cell transformants by human CTL may be due either to an absence on the murine target cells of a ligand required by an accessory molecule on the human CTL, such as LFA-1 (39), LFA-2 (39), or T8 (34-36), or to the absence of a previously undescribed species-specific modifier of the class I molecule (40) . The recognition and lysis of the human cells that express the Kb and the Kbl+2/A2 antigens by mouse CTL demonstrate that cross-species CTL-target cell interactions can occur, a phenomenon not previously observed in the recognition of HLA antigens. The possibility either that the murine CTL clones in our anti-Kb CTL line may have a higher affinity, antigen-specific T-cell receptor and may not require other CTL accessory molecule interactions or that these murine CTL can utilize human target-cell ligands for their CTL accessory molecules needs to be explored. The former hypothesis is supported by the finding that, when surface antigen expression is limiting, primary Kb-allospeciflic CTL, in contrast to a selected long-term CTL line, more readily lyse L-cell than RD-cell transformants (data not shown). Thus, with repeated antigenic stimulation, the murine H-2Kb_ specific CTL line may be enriched for high-affinity CTL clones that do not require accessory cell molecules. In contrast, after primary antigenic stimulation, fewer highaffinity clones may be generated, and thus the bulk CTL population may have a greater dependence on the presence of CTL accessory antigens.
